BRIEF published on 07/22/2026 at 14:48, 3 months 21 days ago Marinomed Biotech AG Seeks Court Restructuring amid Market Challenges Marinomed Biotech AG Market Liquidity Raiffeisen Bank Marinosolv® Platform Court Restructuring
BRIEF published on 07/22/2026 at 14:48, 3 months 21 days ago Marinomed Biotech AG demande une restructuration judiciaire face aux difficultés du marché Marinomed Biotech AG Liquidité Du Marché Banque Raiffeisen Restructuration Judiciaire Plateforme Marinosolv®
BRIEF published on 07/22/2026 at 14:41, 3 months 21 days ago Amundi Physical Metals plc: UK Final Terms Announced London Stock Exchange Amundi Physical Metals ETC Securities Final Terms Gold Exposure
BRIEF published on 07/22/2026 at 14:41, 3 months 21 days ago Amundi Physical Metals plc : Annonce des conditions définitives au Royaume-Uni Bourse De Londres ETC Securities Conditions Finales Exposition À L'or Métaux Physiques Amundi
BRIEF published on 07/22/2026 at 14:40, 3 months 21 days ago Wi2Wi Corp. Achieves Notable Manufacturing Yield Boost Operational Excellence Process Optimization Defense And Aerospace Gross Margin Expansion Manufacturing Yield
BRIEF published on 07/22/2026 at 14:40, 3 months 21 days ago Wi2Wi Corp. enregistre une hausse notable de son rendement de production Excellence Opérationnelle Défense Et Aérospatiale Optimisation Des Processus Rendement De Fabrication Expansion De La Marge Brute
BRIEF published on 07/22/2026 at 14:38, 3 months 21 days ago Amundi Physical Metals plc Releases Final Terms for Gold ETC Financial Markets Amundi Physical Metals Gold ETC Final Terms Securities Issuance
BRIEF published on 07/22/2026 at 14:38, 3 months 21 days ago Amundi Physical Metals plc publie les conditions finales de l'ETC Or Marchés Financiers Or ETC Émission De Titres Conditions Finales Métaux Physiques Amundi
BRIEF published on 07/22/2026 at 14:35, 3 months 21 days ago NanoViricides Applies for Phase II Trials of NV-387 Oral Gummies for Ebola in DRC NanoViricides NV-387 Clinical Trial DRC Ebola
BRIEF published on 07/22/2026 at 14:35, 3 months 21 days ago NanoViricides demande l'autorisation d'effectuer des essais de phase II sur ses gommes orales NV-387 contre Ebola en RDC NanoViricides NV-387 Essai Clinique RDC Ebola
Published on 11/13/2026 at 02:40, 5 hours 24 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 5 hours 54 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 8 hours 39 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 8 hours 59 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 9 hours 4 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/13/2026 at 07:48, 16 minutes ago Nagarro releases unaudited Q3 2026 results, posts 2.7% constant currency growth for 9 months ended September 2026
Published on 11/13/2026 at 07:30, 34 minutes ago Mutares seeks early refinancing of the outstanding Bond 2023/2027 by increasing the Bond 2024/2029 by up to EUR 165 million
Published on 11/13/2026 at 07:29, 35 minutes ago Bechtle delivers double-digit growth in business volume and EBT, raises 2026 forecast again
Published on 11/13/2026 at 07:15, 49 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers continued core growth despite mixed end-market demand, led by strong Opto Semiconductors
Published on 11/13/2026 at 07:14, 50 minutes ago Fabasoft Reports Revenue and Earnings Growth in the First Half of Fiscal Year 2026/2027
Published on 11/13/2026 at 08:00, 4 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 8 hours 51 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 8 hours 51 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 9 hours 4 minutes ago Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 13 hours 28 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
